tirzepatide 2.5 179.00 | --- 45 mg / ml --- 2.5 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) Eli Lilly: Tirzepatide Single-Dose Vials

Most patients who experience energy improvements notice them after 3-6 months of treatment as metabolic changes occur, weight decreases, and side effects diminish

PlexusDx helps you navigate GLP-1 treatment with personalized dosing and genetic insights to minimize disruptions to your daily life

Increase GLP-1 by up to 22%

Apart from its metabolic effects, GLP-1 plays a key role in gastrointestinal motility

It will be recommended to repeat lab work in 3-4 months while on therapy to assess response

There are also generics for orally administered GLP-1 Agonists, but at this time we do not provide them as their clinical efficacy isnt as well researched